Skip to content

Enhancing the Functionality of Human Bone Marrow-Derived Mesenchymal Stromal Cells Using Signaling Modulators.

· Methods in molecular biology · Vol 3074, pp. 529-541 · 0 citations
Medicine

TL;DR

This chapter describes two in vitro assays designed to assess the hematopoietic stem/progenitor cell (HSPC)-supporting capacity of primed MSCs, and the other is specifically aimed at their ability to support the growth of primitive HSCs.

View source

Similar papers

2026

Isolation and Characterization of Mesenchymal Stem Cells from Human Umbilical Cord Tissue.

A protocol to isolate and expand MSCs from human umbilical cord tissue and characterize their cell surface protein expression by flow cytometry, self-renewal potential by colony-forming assay, and tri-lineage differentiation capacity is outlined.

Yi-Xuan Dai, Avital Mendelson · 0 citations
Open access Sep 2026

Human Mesenchymal Stromal Cells from Bone Marrow and Neonatal Sources: A Comparative In Vitro Study of Their Myelopoietic and Lymphopoietic Supportive Capacity from Hematopoietic Progenitor Cells

Background/Objectives: Mesenchymal stromal cells (MSCs) isolated from neonatal sources have been proposed in clinical cell therapy to enhance hematopoietic stem cell transplantation due to their hematopoietic support capacity. Here we evaluated this capacity, particularly the lymphopoietic potential that remains poorly...

Ixel Luna-Cañedo, G. Fajardo-Orduña, R. Pelayo et al. · 0 citations
Review Open access Sep 2026

Mesenchymal stem/stromal cell senescence in aging and regenerative medicine: a systematic review

These cells can be isolated from a wide range of human tissues, including bone marrow (BM-MSCs), adipose tissue (AD-MSCs), dental tissues, such as dental pulp stem cells (DPSCs) and periodontal ligament stem cells (PDLSCs), as well as umbilical cord cells (UC-MSCs), including Wharton’s jelly–derived MSCs (UC-MSCs-WJ) a...

Letícia Odaguiri Watanabe, Luana Roleto Cardoso, Johnny Carvalho da Silva et al. · 0 citations
Aug 2026

Homing Assessment of Human Placenta-Derived Mesenchymal Stromal Cells in Immunodeficient NOG Mice Following Sublethal Irradiation

Background: Mesenchymal stromal cells (MSCs) are among the most extensively studied candidates for cell-based therapy. The homing capacity of MSCs is a critical factor influencing the efficacy of MSC-based therapies. This study aimed to investigate the homing of placenta-derived mesenchymal stromal cells (PD-MSCs) in v...

Nasser Ahmadbeigi, S. Muhammadnejad, A. Muhammadnejad et al. · 0 citations
Open access Aug 2026

Human iPSC-derived bone marrow organoids with integrated hematopoietic and T cell-supportive niches

This integrated bone marrow organoid platform provides a physiologically relevant system for studying human hematopoietic development and immune cell differentiation and offers a scalable foundation for regenerative medicine and immunotherapy applications.

Jiyoung Lee, Tomoyuki Kawasaki, Lilika Tabata et al. · 0 citations
Open access Aug 2026

Keratin 8 enhances the efficacy of mesenchymal stem cells in preventing acute graft-versus-host disease.

BACKGROUND Acute graft-versus-host disease (aGVHD) remains a leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The development of methods that preserve graft-versus-leukemia (GVL) activity while preventing aGVHD remains a long-sought goal. Recent studies sugg...

Ya Zhou, Rui Wang, Zheng Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.